Identifying the characteristics of dementia that are caused by traumatic brain injury could prevent people from being misdiagnosed with Alzheimer’s disease.
The research, conducted at the UCLA Alzheimer’s and Dementia Care Program, also shows that the program was cost-neutral after accounting for its costs.
The study not only revealed the promise of goal attainment in dementia care, but also the importance of goal setting for caregivers, who are affected both emotionally and physically by their loved one’s illness.
The research “may reassure some people that despite testing positive on screening tests, their chances of developing Alzheimer’s disease dementia is low,” said UCLA’s Ron Brookmeyer.
UCLA research provides critical knowledge for medicinal chemists to begin designing new drugs based on cambinol that are more potent than the molecule itself.
If replicated in larger studies, the findings could lead to new types of programs to improve mental agility in older adults by combining mental training with physical fitness.
UCLA geneticist Dr. Wayne Grody UCLA geneticist says many people are ill-equipped to handle troubling medical information without the guidance of physicians.
Protein-imaging method developed by new UCLA researcher overcomes challenges of current techniques, offering untold potential in the exploration of disease and treatment.
The scientists believe the technique, which focuses on cells’ mitochondria, could eventually lead to a way to delay the onset of Parkinson’s disease, Alzheimer’s disease and cancer.
"“Dementia is an isolating disease that can bring on loneliness and is often void of opportunities for social interactions,” says Dr. Zaldy Tan, UCLA gerontologist and director of TimeOut @ UCLA.
UCLA School of Nursing researchers found that people with a certain genetic variation who took donepezil for the condition had a faster cognitive decline than those who took a placebo.